Self-Management and Resourceful Transition of Type 2 Diabetes With Stage 3 Kidney Disease (SMaRT)
|ClinicalTrials.gov Identifier: NCT01067963|
Recruitment Status : Terminated
First Posted : February 12, 2010
Last Update Posted : June 9, 2015
|Condition or disease||Intervention/treatment|
|Diabetes Mellitus, Type 2 Renal Insufficiency, Chronic||Behavioral: Computer assisted education and motivational interviewing. Behavioral: Group talks/social chat|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||80 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Self-management of Type 2 Diabetes and Chronic Kidney Disease|
|Study Start Date :||December 2009|
|Primary Completion Date :||October 2012|
|Study Completion Date :||October 2012|
Computer assisted education and telephone counseling using motivational interviewing.
Computer assisted education and motivational interviewing
Behavioral: Computer assisted education and motivational interviewing.
9 study contact points. 3-week intervention using computer-assisted learning modules and telephone counseling using motivational interviewing.
Other Name: Experimental Group
Placebo Comparator: Group talks/social chat
Group session talks on general topics about healthy lifestyle, printed power point handouts, telephone calls comprised of social conversation to discuss the handout content.
Behavioral: Group talks/social chat
9 study contact points. 3 group talk session on general topics about healthy lifestyle, printed power point handouts, telephone calls comprised of social conversation to discuss the handout content.
Other Name: Attention Control Group
- Primary outcomes utilized in this study will be disease burden (measured as diabetes-related distress), quality of life (measured as health related QOL), and glycemic health (measured as hemoglobin A1C). [ Time Frame: One year ]
- Secondary exploratory outcomes for quality of life include measures of health-related quality of life for diabetes and overall quality of life. [ Time Frame: One year ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01067963
|United States, Colorado|
|University of Colorado Hospital|
|Aurora, Colorado, United States, 80045|
|VA Eastern Colorado Hospital|
|Denver, Colorado, United States, 80220|
|Principal Investigator:||Teresa J. Sakraida, PhD, RN||University of Colorado Denver College of Nursing|
|Principal Investigator:||Alkesh Jani, MD||University of Colorado Denver, School of Medicine and VA Eastern Colorado Hospital|